Author Archives: Sonia Canzater

12.22.16

Obama signs $6.3 billion Cures Act – But Does it Do More Harm than Good?

By | Leave a Comment

On December 13th, President Obama signed the 21st Century Cures Act into law. This law provides $6.3 billion for cancer cure research, and to address the growing opioid drug abuse epidemic. The Act also allows for a more streamlined approval process for the FDA to bring new drugs and medical devices to the market. While […]

Posted in FDA, Health reform, uncategorized ; Tagged: , .

11.21.16

Now What?? The Potential Effects of a Trump Administration and Republican-Controlled Congress on Hepatitis C care

By | Leave a Comment

The 2016 presidential election ended in a result that few who are passionate about public health, human rights, and race, gender and sexual orientation equality could have ever wanted. However, as we face the reality of this reality, we who work to improve health outcomes must steel our resolve and continue to address the critical […]

Posted in Health reform, Healthcare ; Tagged: , .

10.26.16

GET YOUR FLU SHOT, OR WE ALL PAY THE PRICE! Unvaccinated adults are a costly economic burden every year in the U.S.

By | Leave a Comment

    Many of us have seen the signs at work, gotten the emails from our health care insurer, or heard the ads on the radio telling us that it is flu season, and thus time to get an annual flu shot.  Many Americans will comply with this yearly health edict, but many will challenge medical wisdom […]

Posted in Global Health, Healthcare, uncategorized ; Tagged: , , , .

09.29.16

O'Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Posted in Healthcare, uncategorized ; Tagged: , .

09.29.16

O’Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By | Leave a Comment

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Posted in Healthcare, uncategorized ; Tagged: , .

08.08.16

Spike in hepatitis C rates in young women further supports the need for screenings for all pregnant women

By | Leave a Comment

As the rate of Hepatitis C infections among young Americans increases, so does the risk of infections in infants. The CDC reports a 22% increase between 2011 and 2014  in HCV infections in women of childbearing age, between 15-44 years.  There was also a 14% increase in infections in children 2 years and younger seen during […]

Posted in Health reform, Healthcare, uncategorized ;

07.08.16

Viral Hepatitis is the seventh leading cause of death worldwide: Yet U.S. treatment interventions continue to go underfunded

By | Leave a Comment

An article published on July 6, 2016 in The Lancet ranks viral hepatitis infections – specifically both Hepatitis B (HBV) and Hepatitis C (HCV) – as the seventh leading cause of death worldwide in 2013, up from tenth in 1990. Where other infectious diseases such as tuberculosis, malaria and diarrheal diseases saw sharp declines over this timespan, HBV […]

Posted in Global Health, Health reform, uncategorized ;

06.08.16

Litigation is forcing States to finally stop restricting Hepatitis C treatment for Medicaid recipients

By | Leave a Comment

Last week, a federal judge in Washington State ruled that the state Medicaid authority cannot place undue limitations on access to Hepatitis C (HCV) drugs for patients, as Medicaid has the duty to provide “medically necessary” treatment to the patients it covers. Until this ruling, many states, including Washington, citing the high cost of the […]

Posted in uncategorized ;

05.05.16

May is National Hepatitis Awareness Month: Hepatitis C testing is critically important as CDC reports infection rates and deaths in U.S. at all-time high

By | Leave a Comment

May is National Hepatitis Awareness Month. The CDC has designated May 19th, 2016 as National Hepatitis Testing Day in the U.S. This campaign is particularly timely this year given the report released this Wednesday by the CDC  which states that new infections and deaths caused by Hepatitis C (HCV) are at the highest rates ever reported. […]

Posted in Health reform, Healthcare ; Tagged: , .

04.05.16

HHS guidance on syringe service programs provides substantive support for HCV and HIV infection reduction efforts among injection drug users.

By | Leave a Comment

On March 29, 2016, the Department of Health and Human Services released guidance to assist state and local health departments to request permission to use federal funds for Syringe Support Programs (SSPs). This guidance is in response to bipartisan legislation passed in December 2015 that relaxed previous restrictions on federal funds being used for any […]

Posted in Healthcare, Resources, uncategorized ; Tagged: , , , .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.